Fair Market Value for the Physicians

The investigators and the sponsors are the two ends in deciding the fair market value compensation in the clinical trial. How is this fair market value decided? Most of health care industries go by referral data provided in the market which is not a acceptable methodology or you should never go ahead with the going rate of the physician to decide the fair market value. The date provided in the market referrals should no longer be considered, this will increase the cost of your clinical trial rather. Establishing the compensation based on the few considerations will benefit in two ways, cutting down the time period of the clinical trial and reducing the expense by avoiding the duplicate costs.

A plat from should be set to understand the services provided, qualifications, and regulatory guide lines. Payments should be made based on measurable improvements in the quality of the work. All these should be documented ideally and need a continuous negotiations throughout the process. The medical affair services provided by the clinical trial cost management companies would from best plat form to conclude the fair market value compensation paid to the physician. They also render the services that are helpful in deciding the fair market value.